Dana-Farber Cancer Institute

The treatment landscape for pancreatic cancer is evolving, following practice-changing research results presented by Brian Wolpin, MD, MPH, director of the Hale Family Center for Pancreatic Cancer Research, at the 2026 American Society of Clinical Oncology Annual Meeting.

From RAS therapeutics to other emerging advances, our experts are focused on three key areas poised to shift how pancreatic cancer is detected and treated. ⬇️

Three Ways Research Could Improve Pancreatic Cancer Treatment Published: November 3, 2025Updated: June 9, 2026Pancreatic cancer has long been difficult to detect and treat, but that might be changing. Dana-Farber experts in the Hale Family Center for Pancreatic Cancer Research are focused on three key areas that are poised to shift the way people think about,...